This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A phase III single arm study to evaluate the effic...
Clinical trial

A phase III single arm study to evaluate the efficacy, safety and local tolerability of a subcutaneous 3?month formulation of triptorelin pamoate (11.25�mg) in patients with locally advanced or metastatic prostate cancer.

Read time: 1 mins
Last updated:9th Oct 2012
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest